Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 139

1.

Atrial fibrillation, stroke, and quality of life.

Chinitz JS, Castellano JM, Kovacic JC, Fuster V.

Ann N Y Acad Sci. 2012 Apr;1254:140-50. doi: 10.1111/j.1749-6632.2012.06494.x. Review.

PMID:
22548580
2.

'Real-world' antithrombotic treatment in atrial fibrillation: The EORP-AF pilot survey.

Lip GY, Laroche C, Dan GA, Santini M, Kalarus Z, Rasmussen LH, Ioachim PM, Tica O, Boriani G, Cimaglia P, Diemberger I, Hellum CF, Mortensen B, Maggioni AP.

Am J Med. 2014 Jun;127(6):519-29.e1. doi: 10.1016/j.amjmed.2013.12.022. Epub 2014 Jan 28.

PMID:
24486284
3.

Anticoagulation for stroke prevention in elderly patients with atrial fibrillation, including those with falls and/or early-stage dementia: a single-center, retrospective, observational study.

Jacobs LG, Billett HH, Freeman K, Dinglas C, Jumaquio L.

Am J Geriatr Pharmacother. 2009 Jun;7(3):159-66. doi: 10.1016/j.amjopharm.2009.06.002.

PMID:
19616184
4.

Stroke prevention in atrial fibrillation: putting the guidelines into practice.

Mant J, Edwards D.

Drugs Aging. 2010 Nov 1;27(11):859-70. doi: 10.2165/11538620-000000000-00000. Review.

PMID:
20964460
5.

Canadian Cardiovascular Society atrial fibrillation guidelines 2010: prevention of stroke and systemic thromboembolism in atrial fibrillation and flutter.

Cairns JA, Connolly S, McMurtry S, Stephenson M, Talajic M; CCS Atrial Fibrillation Guidelines Committee.

Can J Cardiol. 2011 Jan-Feb;27(1):74-90. doi: 10.1016/j.cjca.2010.11.007.

PMID:
21329865
6.

Stroke prevention in atrial fibrillation: current anticoagulation management and future directions.

Fitzgerald BT, Cohn SL, Klein AL.

Cleve Clin J Med. 2005 Apr;72 Suppl 1:S24-30. Review.

PMID:
15853176
7.

Stroke prevention in elderly patients with atrial fibrillation.

Lew SJ, Lim JK.

Singapore Med J. 2002 Apr;43(4):198-201.

PMID:
12188065
8.

An update on antithrombotic therapy in atrial fibrillation: the role of newer and emergent drugs.

Deedwania P, Huang GW.

Rev Cardiovasc Med. 2012;13(2-3):e89-104. Review.

PMID:
23160166
9.
10.

Stroke prevention in atrial fibrillation patients.

Marinigh R, Lip GY, Lane DA.

Expert Opin Pharmacother. 2010 Oct;11(14):2331-50. doi: 10.1517/14656566.2010.498819. Review.

PMID:
20718589
11.
12.

What is the most effective and safest delivery of thromboprophylaxis in atrial fibrillation?

Lip GY.

J R Coll Physicians Edinb. 2012;42 Suppl 18:35-44. doi: 10.4997/JRCPE.2012.S04.

PMID:
22518392
13.

Benefits and risks of oral anticoagulation for stroke prevention in nonvalvular atrial fibrillation.

Garcia DA.

Thromb Res. 2012 Jan;129(1):9-16. doi: 10.1016/j.thromres.2011.09.023. Epub 2011 Oct 21. Review.

PMID:
22018997
14.

[Atrial fibrillation and stroke].

Aamodt AH, Sandset PM, Atar D, Tveit A, Russell D.

Tidsskr Nor Laegeforen. 2013 Aug 6;133(14):1453-7. doi: 10.4045/tidsskr.12.0850. Review. Norwegian.

15.

Applying antithrombotic therapies to improve outcomes in patients with atrial fibrillation.

Cannon C, Ezekowitz MD, Granger C.

Am J Cardiol. 2013 Aug 15;112(4):S3. doi: 10.1016/j.amjcard.2013.06.003.

PMID:
23910054
16.

Management of nonvalvular atrial fibrillation: a comprehensive approach.

Iuliano L, Di Matteo A, Straface G.

Indian J Med Sci. 2009 Sep;63(9):419-30. doi: 10.4103/0019-5359.56111. Review.

PMID:
19805924
17.

Can we predict stroke in atrial fibrillation?

Lip GY.

Clin Cardiol. 2012 Jan;35 Suppl 1:21-7. doi: 10.1002/clc.20969. Review.

18.

Is bleeding a necessary evil? The inherent risk of antithrombotic pharmacotherapy used for stroke prevention in atrial fibrillation.

Myat A, Ahmad Y, Haldar S, Tantry US, Redwood SR, Gurbel PA, Lip GY.

Expert Rev Cardiovasc Ther. 2013 Aug;11(8):1029-49. doi: 10.1586/14779072.2013.815423. Review.

PMID:
23984927
19.

Striking a balance between the risks and benefits of anticoagulation bridge therapy in patients with atrial fibrillation: clinical updates and remaining controversies.

Garwood CL, Hwang JM, Moser LR.

Pharmacotherapy. 2011 Dec;31(12):1208-20. doi: 10.1592/phco.31.12.1208. Review.

PMID:
22122182
20.

Stroke and thromboembolism in atrial fibrillation: a systematic review of stroke risk factors, risk stratification schema and cost effectiveness data.

Hughes M, Lip GY; Guideline Development Group, National Clinical Guideline for Management of Atrial Fibrillation in Primary and Secondary Care, National Institute for Health and Clinical Excellence.

Thromb Haemost. 2008 Feb;99(2):295-304. doi: 10.1160/TH07-08-0508. Review.

PMID:
18278178

Supplemental Content

Support Center